Pt. Buana Benoa Kencana
FDA import alert and refusal historyDenpasar, IndonesiaFEI 3001650120
As of October 26, 2026, Pt. Buana Benoa Kencana (Denpasar, Indonesia) is on the red list of FDA Import Alert 16-81 (Seafood products: Salmonella) for raw tuna, published by FDA on August 18, 2010, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-81 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Pt. Buana Benoa Kencana
1 record, newest first. Each line links to the FDA page it came from.
2010
- Import alert listingListed on Import Alert 16-81red listRaw tunaSource
Questions about Pt. Buana Benoa Kencana
- Is Pt. Buana Benoa Kencana on an FDA import alert?
- Yes. As of October 26, 2026, Pt. Buana Benoa Kencana is on the red list of FDA Import Alert 16-81, “Seafood products: Salmonella”, for raw tuna; FDA published the listing on August 18, 2010.
- Has FDA refused shipments from Pt. Buana Benoa Kencana?
- No FDA import refusals for Pt. Buana Benoa Kencana appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Pt. Buana Benoa Kencana's FEI number?
- Pt. Buana Benoa Kencana's FDA Establishment Identifier (FEI) is 3001650120.
- Can shipments from Pt. Buana Benoa Kencana still enter the U.S.?
- Shipments of raw tuna from Pt. Buana Benoa Kencana can be detained without physical examination under Import Alert 16-81; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Pt. Buana Benoa Kencana?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.